For better or worse? Investigating the validity of best-worst discrete choice experiments in health.


Journal

Health economics
ISSN: 1099-1050
Titre abrégé: Health Econ
Pays: England
ID NLM: 9306780

Informations de publication

Date de publication:
04 2019
Historique:
received: 24 08 2017
revised: 15 11 2018
accepted: 29 11 2018
pubmed: 15 2 2019
medline: 17 7 2020
entrez: 15 2 2019
Statut: ppublish

Résumé

Discrete choice experiments (DCEs) are frequently used in health economics to measure preferences for nonmarket goods. Best-worst discrete choice experiment (BWDCE) has been proposed as a variant of the traditional "pick the best" approach. BWDCE, where participants choose the best and worst options, is argued to generate more precise preference estimates because of the additional information collected. However, the validity of the approach relies on two necessary conditions: (a) best and worst decisions provide similar information about preferences and (b) asking individuals to answer more than one choice question per task does not reduce data quality. Whether these conditions hold in empirical applications remains under researched. This is the first study to compare participants' choices across three experimental conditions: (a) BEST choices only, (b) WORST choices only, and (c) BEST and WORST choices (BWDCE). We find responses to worst choices are noisier. Implied preferences from the best only and worst only choices are qualitatively different, leading to different WTP values. Responses to BWDCE tasks have lower consistency, and respondents are more likely to use simplifying decision heuristics. We urge caution in using BWDCE as an alternative to the traditional "pick the best" DCE.

Identifiants

pubmed: 30761661
doi: 10.1002/hec.3869
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

572-586

Subventions

Organisme : Chief Scientist Office
ID : HERU1
Pays : United Kingdom
Organisme : Health Foundation
ID : THF 7264
Pays : International
Organisme : the French National Institute for Cancer
Pays : International

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2019 John Wiley & Sons, Ltd.

Auteurs

Nicolas Krucien (N)

Health Economics Research Unit, University of Aberdeen, Aberdeen, UK.

Jonathan Sicsic (J)

LIRAES (EA 4470), University Paris Descartes, Sorbonne-Paris-Cité, Paris, France.

Mandy Ryan (M)

Health Economics Research Unit, University of Aberdeen, Aberdeen, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH